Halozyme Therapeutics, Inc.
$107.72
+1.23 (+1.16%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +30.9%
- 3 Months
- +62.5%
- YTD
- +60.1%
- 1 Year
- +47.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 37.1%
- Largest decline max drawdown, since Aug 2025
- -24.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.22
Own HALO?
See how HALO contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.